Tag: entrepreneurs
-
Univ. Spin-Off Develops Head Impact Sports Sensor
Two chemistry faculty in Michigan developed a simple sensor that measures the force and shows the location of head impacts in contact sports, and started a company to develop the product.
-
Process Converts Food Waste to Auto Tire Materials
Agricultural scientists in Ohio are developing a process for converting common food waste into materials used in car tires, and filed a patent for these techniques.
-
Air Sampling Device Finds Unreported Allergens
A system designed to sample the air in homes of people with allergies found a number of airborne allergens in residences that previously went undetected by other devices.
-
Cancer Blood Test Company Raises $65M in Early Funds
Freenome, a company applying machine learning to analysis of liquid biopsies, is raising $65 million in its first round of venture financing.
-
Mastering The Mail For Business
If you’re a business that is into the making and selling of physical products, getting that product out to customers is possibly the most important stage of business for your company.
-
Test of Nasal Skin Cells Found to Detect Lung Cancer
A diagnostic test analyzing the genes in skin cells from nasal passages can detect lung cancer, and the absence of cancer, as accurately as more invasive samples from the airways.
-
Duchenne Gene-Editing Company Launched, Raising $5M
A biotechnology start-up is applying a process for editing-out disease-causing mutations to correct the inherited disorder Duchenne muscular dystrophy.
-
Nuclear Cancer Therapy Company Launches, Raises $25M
A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario.
-
Handheld Surgical Assist Device in Development
A handheld mechanical device that promises to reduce the cost and ease the work of minimally invasive surgery is being created by a spin-off company from University of Michigan.
-
Patent Issued for Peptides in Diabetes Gene Therapy
A U.S. patent was issued today for synthetic peptides that support gene therapies developed to treat type 2 diabetes and heart failure.